Since the 1990s, interventional cardiovascular disease diagnostic technology has developed rapidly in China, saving the lives of a large number of patients with cardiovascular disease. Because the technology is risky, difficult, expensive, and the patient's condition is relatively acute, it requires a high level of competence on the part of medical institutions and physicians. After the economic interests of the drive, "abuse" and "profiteering" has become the norm.
China's cardiovascular disease interventional diagnosis and treatment technology has increased year by year. Among them, as one of the most important technology of coronary heart disease interventional diagnosis and treatment throughout the year more than 450,000 cases, the use of stents about 680,000. According to incomplete statistics, China's coronary heart disease interventional therapy from 175,000 cases in 2009 to 454,505,000 cases in 2013. 2009 to 2011 three years, China's coronary heart disease interventional therapy cases in the average of each case of stent placement 1.59, in 2013 1.51. In the United States, the average number of stents between January 2010 and June 2011 was 1.4; in Spain, the average number of stents between 1990 and 2011 was 1.50; and in Malaysia, the average number of stents between 2007 and 2009 was 1.58, respectively. It is necessary to strengthen the management and guidance of this technology so that it can develop healthily under the premise of regulation.
So after heart stent surgery, is it a one-off, all-clear? Not necessarily, as far as this kind of profit-driven surgery is concerned, it doesn't put patients' lives first and brings about endless consequences. The "abuse" and "profiteering" are a direct result of the following problems.
Question 1: Are the Chinese getting the most out of a technology that has been phased out internationally?
According to Zhong Zhimin, Director of Cardiovascular Surgery at the Second People's Hospital of Guangdong Province, the main means of treating coronary heart disease is bypass surgery or stent surgery. Surgical treatment (bypass surgery) refers to taking a section of blood vessel from other parts of the patient's own body, and then connecting it to the two ends of narrowed or blocked coronary arteries respectively, so that the blood flow can be bypassed, so that the ischemic myocardium can be supplied with oxygen to alleviate the symptoms of myocardial ischemia. Interventional therapy (stenting) is a cardiac catheterization technique in which a stent or other device is placed into a coronary artery via a vascular puncture through the femoral artery at the base of the thigh or the radial artery in the wrist to relieve the narrowing of the coronary artery.
Experts such as Zhong Zhimin believe it is a complete misunderstanding to say that this technique has been eliminated abroad. Cardiac stents have saved many patients in the acute stage. For patients with acute myocardial infarction, time is life, and the earlier the blood vessel is opened, the better the treatment effect. Stenting is the most effective way to open blood vessels. This technique is one of the common methods of treating coronary heart disease, and the technology has been very mature at home and abroad.
Question 2: Is a heart stent a "time bomb" buried in the body?
According to Yan Qi, director of the cardiology department at Anhui Provincial Hospital, the technology of cardiac stents is also progressing, the first generation is a balloon stent, which is a local anesthesia outside the body, and then put the stent into the stenosis of the blood vessels with a catheter. However, it was later found that nearly half of the patients experienced re-blockage at the site between three and six months after the procedure. In the 1990s, a new type of stent was invented, and the rate of post-procedure re-blockage dropped by 15-30 percent. At present, the most commonly used stent in domestic clinics is the third generation stent, i.e., drug stent, which is attached to the stent to prevent excessive endothelial hyperplasia and calcification of the surgical site, and the chance of re-obstruction of the surgical site in clinical practice is only 5-8%.
"The fourth generation of stents is now biodegradable bioprostheses, which are of course more expensive. All in all, this technology is constantly improving, with fewer and fewer clinical side effects, better and better postoperative results, and is a mature technology that is fully recognized both at home and abroad. The claim that re-blockage will occur if the stent is installed in the post is absolutely alarmist." He said.
Question 3: Either death by stent or death by medicine?
Yan Lik believes that there is also a misinterpretation about taking medication for life. Clinical treatment of coronary heart disease are mainly three kinds of drugs, stents and heart bypass. Of course regardless of taking stents and bypass, drugs are used at the same time. Coronary heart disease patients of course, life-long medication, mediation of blood viscosity, commonly used aspirin and other five kinds of drugs, some of which are calcium channel blockers, some of which are thrombolytic drugs, and some of which are to adjust the blood lipids. And aspirin is mainly used to fight platelets. Even if you don't have a stent, you have to take it for a long time; those who have a bypass also have to take it. Saying that aspirin causes cancer is a joke made by people who simply don't have the slightest bit of medical common sense.
Question 4: Bypass or stent, who's in charge?
"The indication says it all." Zhong Zhimin said. It is reported that the world's annual increase of about 1.7 million "stent people". But stents are not suitable for all patients with coronary heart disease. Generally speaking, for the left trunk lesions, three branch lesions, multiple, multiple, diffuse lesions or the main vascular bifurcation of the lesions, it is recommended that the patient is best to use surgical "bypass" surgery. Because if these lesions are forced into stenting, on the one hand, the operation is prone to problems, and the patient's life is likely to be in danger; on the other hand, many diffuse coronary artery lesions, if the problem is to be solved completely, it is not possible to solve the problem with 2-3 stents, and the chances of restenosis are high in the near future. Therefore, patients should not choose the treatment simply based on "preference", and must strictly follow the indications for surgery. The patient must strictly follow the indications for the surgery. Otherwise, not only will he not get better treatment, but he will also have to bear the high cost.
Experts sorted out the indications and advantages and disadvantages of the two treatments: cardiac bypass surgery for the left trunk lesions, three branch lesions, accompanied by cardiac insufficiency, accompanied by diabetes, coronary heart disease after myocardial infarction complications, etc.; cardiac stenting for coronary artery angiography to determine the degree of stenosis, more than 75% of the frequent occurrence of myocardial infarction, the age of 30-65 years old patients;
The advantage of cardiac bypass grafting is that it can solve severe coronary artery lesions, with good long-term results, while the disadvantage lies in the long operation time, large incisions, and the use of extracorporeal circulators have an impact on other organs; the advantage of stenting is that it is a short operation, minimally invasive, and can be repeatedly placed, while the disadvantage lies in the possibility of vascular restenosis, and the need to re-intervene the chances of a relatively high.
Question 5: After the procedure, is it done once and for all?
Zhong Zhimin said the surgery mainly plays a role in relieving symptoms and stabilizing the condition, and to achieve good results, post-operative care should not be ignored. In addition to adhere to the medication, more rest after surgery, you can appropriate exercise such as walking, but can not be strenuous exercise; scientific arrangement of diet, to ensure that the intake of the right amount of fruits and vegetables and low-fat, high-protein food; a small amount of alcohol, preferably not drinking, the need to socialize with people who can not be more than 50 milliliters per day, smoking is strictly prohibited; after the operation or need to be regularly reviewed physical examination, in order to facilitate the doctor to carry out timely treatment.
Yan radical introduction, now many people live irregularly, big fish and meat, tobacco and alcohol unrestrained, it is easy to lead to high blood fat, blood viscosity decline, sometimes cardiovascular blockage, resulting in myocardial infarction. It is true that cardiac stents are not a once-and-for-all treatment for coronary heart disease. Because the coronary artery of a patient with coronary artery disease has already appeared, so do stenting can only rule out the risk of his current cause of myocardial infarction in the most dangerous parts of the heart, but if his cardiovascular is still continue to deteriorate, continue to appear elsewhere lesions, but also to continue to put the stent.
So is it possible to avoid not having a cardiac stent procedure and still preserve the patient's life and ensure his health? The answer is yes, it can! As long as the patient can often take earth kinase urokinase and other thrombolytic drugs, so that their blood embolism dissolved, the blood vessels open, you can avoid expensive risky stent surgery. Just earthworm kinase urokinase and other thrombolytic drugs these injection drugs, can not be used for a long time, generally can not be used for more than five consecutive days. More than five days there will be patients with life-threatening. Hubei Province, China Garlic Bean Biotechnology Co., Ltd., the production of thrombolytic functional patented food, access to national export inspection-free qualification, safety, no side effects, has been exported to foreign markets. With Hua Garlic Bean prevention and treatment of cardiovascular and cerebrovascular diseases safe, effective, economic, is no substitute.
Can effectively solve this problem. Many heart disease patients in the hospital check, need to do stent surgery, but by taking Chinese garlic beans after two or three months, the embolism is gone, the blood vessels through, there is absolutely no need to go back to the stent surgery. It really is a gospel to heart disease patients.
The effective ingredient of Chinese garlic beans contains thrombolytic enzyme, each 10 grams containing 16,000 units, equivalent to an injection of 800 yuan of urokinase, containing anti-bleeding substances such as vitamin K, soybean polypeptide, lecithin and other ingredients, as well as antimicrobial substances red, can be strong to dissolve the thrombus, promote blood circulation, protection of vascular elasticity, reduce blood lipids, lowering the viscosity of blood, prevention and control of hypertension, prevention and control of myocardial infarction, Cerebral infarction, prevention and treatment of Alzheimer's disease, antibacterial and antiseptic effects, each of which has been proved by a large number of examples. Hua garbanzo bean thrombolytic enzyme through the gastrointestinal activity is not reduced, suitable for oral administration. Some people suggest that the extraction of the active ingredient, made of thrombolytic quasi-drugs, easy to publicize. If this is done, the Chinese garlic bean is no longer the most effective, the safest, the most economical. Although it can be like urokinase, snake venom, locust, earth kinase, streptokinase and other quasi-drugs can dissolve blood clots, but followed by side effects, at any time will cause hemorrhagic syndrome, Chinese garlic beans no longer have its unique qualities.
Indications: high blood viscosity, post-stroke, thrombosis patients, fatty liver patients.
Hua Garlic Beans active ingredients:
1. Thrombolytic enzyme (nattokinase): directly dissolve blood clots.
(Please go to Baidu to search for "nattokinase" for more details)
2. Soybean polypeptide: lowering blood lipids, lowering cholesterol, lowering blood pressure, increasing bone density, and protecting blood vessel elasticity.
(Please go to Baidu to search for "soy peptide" for more information)
3. Lecithin: decompose fats and oils, promote blood circulation, remove peroxides, lowering blood lipids, lowering cholesterol, eliminating atherosclerosis.
(Please go to Baidu and search for "lecithin" to learn more)
4. Soy isoflavones: strengthen the female ovarian function, slow down the menopause syndrome.
(Please go to Baidu and search for "soy isoflavones" to learn more)
5. Vitamin K: Anti-bleeding.
(Please go to Baidu to search for "vitamin K" to learn more)
Learn more about health knowledge, please pay attention to the headline "Xicheng Miscellaneous"